DENVER, July 31, 2025 /PRNewswire/ -- QuantiPath.bio, a biotechnology company redefining food safety through precision genetic diagnostics, today announced the addition of two accomplished...
CHICAGO, July 31, 2025 /PRNewswire/ -- The Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC), welcomed thousands of laboratory experts to ADLM 2025...
ABUJA, Nigeria and NEWPORT BEACH, Calif., July 30, 2025 /CNW/ -- In a landmark collaboration aimed at accelerating innovation, capacity building, and digital transformation...
ABUJA, Nigeria and NEWPORT BEACH, Calif., July 30, 2025 /PRNewswire/ -- In a landmark collaboration aimed at accelerating innovation, capacity building, and digital transformation...
ABUJA, Nigeria and NEWPORT BEACH, Calif., July 30, 2025 /PRNewswire/ -- In a landmark collaboration aimed at accelerating innovation, capacity building, and digital transformation...
ABUJA, Nigeria and NEWPORT BEACH, Calif., July 31, 2025 /PRNewswire/ -- In a landmark collaboration aimed at accelerating innovation, capacity building, and digital transformation...
SOUTHAMPTON, England, July 30, 2025 /PRNewswire/ -- MODERNISED (NIHR207538), a multi-site UK clinical study has passed a key milestone: over 450 participants have joined the...
SOUTHAMPTON, England, July 30, 2025 /PRNewswire/ -- MODERNISED (NIHR207538), a multi-site UK clinical study has passed a key milestone: over 450 participants have joined the...
ATLANTA, July 30, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it...
BURLINGTON, Mass., July 30, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 10th Annual Needham Virtual...
Arkstone, an innovative biotechnology company democratizing infectious disease expertise and fighting antimicrobial resistance, has been acquired by global healthcare private equity firm ARCHIMED, which...
BINYAMINA, Israel and CARY, N.C., July 30, 2025 /PRNewswire/ -- OncoHost, a leader in precision oncology leveraging proteomics and AI to personalize cancer care, today...
The triple-negative breast cancer market is expected to grow due to rising incidence rates, increasing awareness, advancements in targeted therapies, ongoing clinical trials, improved...